Search results
Author(s):
Satoshi Higa
,
Li-Wei Lo
,
Shih-Ann Chen
Added:
3 years ago
Catheter ablation of AF has become an established therapy and may have the potential to cure this most commonly encountered sustained arrhythmia. Previous studies have demonstrated that pulmonary veins (PVs) are a major source of the ectopic beats that initiate AF. PV isolation in patients with symptomatic paroxysmal AF refractory to antiarrhythmic drugs is effective; however, it is difficult to…
View more
Author(s):
Rakesh Latchamsetty
,
Fred Morady
Added:
3 years ago
Catheter ablation of AF has shown steady growth over the past two decades with a nearly 15 % annual increase in the US.1 This growth can be attributed in large part to four factors: an increase in operators and institutions performing the procedure;2 a steady rise in AF prevalence, which is predicted to reach 12 million in the US by 2030;3 a larger spectrum of AF patients with more complex atrial…
View more
Added:
6 years ago
Author(s):
Michael Timothy Brian Pope
,
John Paisey
,
Paul Richard Roberts
Added:
1 year ago
Author(s):
Andreas Metzner
,
Erik Wissner
,
Tina Lin
,
et al
Added:
3 years ago
Atrial fibrillation (AF) is the most common cardiac arrhythmia affecting 1.5–2 % of the general population.1 In the current clinical guidelines, catheter ablation is recommended in addition to drug-based antiarrhythmic therapy for patients suffering from symptomatic, drugrefractory AF. However, catheter ablation, if performed at an experienced centre, may also serve as first-line therapy in…
View more
Author(s):
Benedict Wiles
,
Anthony C Li
,
Michael C Waight
,
et al
Added:
1 year ago
Author(s):
Maria Min-Young Kim
Added:
2 years ago
In this interview, Dr Maria Min-Young Kim (Imperial College Healthcare NHS Trust, London, UK) discusses the results of the GANGLIA-AF Trial, a study that aimed to determine the role of ectopy-triggering ganglionated plexus ablation (ET-GP) in the treatment of Atrial Fibrillation.
Questions:
1. Please summarise the main aims, study design and endpoints of this trial?
2. What were your key…
View more
Author(s):
Federico Lombardi
Added:
3 years ago
Atrial fibrillation (AF) is the most common clinical arrhythmia with a relevant socio-economic impact.1–3 Patients with atrial fibrillation are characterised by symptoms such as palpitations and shortness of breath; they have reduced exercise capacity and are subject to a higher risk of thromboembolic events. In spite of a relatively simple diagnosis, management of AF patients is difficult for…
View more
Obesity and Atrial Fibrillation
Author(s):
Vishal Vyas
,
Pier D Lambiase
Added:
3 years ago
Article
Author(s):
Khang-Li Looi
,
Anthony SL Tang
,
Sharad Agarwal
Added:
3 years ago
Heart failure (HF) is a growing and major health burden in western countries. The prevalence of HF is estimated at 1–2 % in the western world, and the incidence approaches 5–10 per 1,000 persons per year.1Cardiac resynchronisation therapy (CRT) has been shown in multiplestudies to improve HF symptoms, quality of life and improve survivals.2–6The two landmark studies, Comparison of Medical Therapy…
View more